The Risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma; A Systematic Review and Meta-Analysis.

Aesthetic plastic surgery 2024 Vol.48(24) p. 5315-5328

Elameen AM, AlMarakby MA, Atta TI, Dahy AA

관련 도메인

Abstract

[BACKGROUND] Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an emerging disorder that has gained global attention throughout the past era. The present meta-analysis was performed to retrieve the risk of BIA-ALCL from population-based epidemiological studies. Factors associated with BIA-ALCL were evaluated to identify patients at higher risk of BIA-ALCL.

[METHODS] A systematic literature search was executed throughout 12 databases. All epidemiological studies encompassing patients with breast implants either for aesthetic or reconstructive purposes and reported the risk of BIA-ALCL were included. Studies reported the risk factors of BIA-ALCL were included.

[RESULTS] The present meta-analysis included 17 articles, encompassing 525,475 patients with breast implants. There were 254 patients with BIA-ALCL with a mean duration to the diagnosis of BIA-ALCL of 13.16 years (95% CI 11.7-14.6, P < 0.001). There were 44 patients with textured breast implants and two with smooth implants. Patients with breast implants were 28.86 times more at high risk of BI-ALCL (95% CI 3.123-266.681). The risk ranged from 0 to 1 per 1000 cases with breast implants, with a similar risk among patients seeking aesthetic and reconstructive surgeries. The risk was 0 to 1 case per 1000 cases among patients with textured breast implants. There was a significant association between the history of breast cancer and BIA-ALCL (P = 0.0016).

[CONCLUSION] This meta-analysis confirmed the association between breast implants and ALCL. There was a similar risk of BIA-ALCL among patients with aesthetic or reconstructive surgeries. Patients with a history of breast cancer were at higher risk of BIA-ALCL.

[LEVEL OF EVIDENCE III] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 11
합병증 bia-alcl 보형물연관 역형성대세포림프종 dict 11
합병증 anaplastic large cell lymphoma 보형물연관 역형성대세포림프종 dict 2
해부 smooth scispacy 1
약물 [BACKGROUND] Breast implant-associated anaplastic large cell lymphoma scispacy 1
약물 CI 3.123 scispacy 1
질환 Breast Implant-Associated Anaplastic scispacy 1
질환 Breast implant-associated anaplastic large cell lymphoma C4528210
Breast implant-associated anaplastic large-cell lymphoma
scispacy 1
질환 breast cancer C0006142
Malignant neoplasm of breast
scispacy 1
질환 ALCL C0206180
Ki-1+ Anaplastic Large Cell Lymphoma
scispacy 1
질환 breast implants were 28.86 times scispacy 1
기타 patients scispacy 1

MeSH Terms

Humans; Lymphoma, Large-Cell, Anaplastic; Breast Implants; Female; Breast Neoplasms; Risk Assessment; Risk Factors; Breast Implantation

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문